BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2961576)

  • 1. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
    De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
    Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.
    Whiteside TL; Miescher S; Hurlimann J; Moretta L; von Fliedner V
    Cancer Immunol Immunother; 1986; 23(3):169-78. PubMed ID: 3024832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.
    Radrizzani M; Quaia M; Benedetti B; Andreola S; Vaglini M; Galligioni E; Fossati G; Parmiani G
    Cancer Immunol Immunother; 1989; 30(4):233-8. PubMed ID: 2574630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2-induced lymphoproliferative responses.
    Winkelstein A; Weaver LD; Salva N; Machen LL
    Cancer Immunol Immunother; 1990; 32(2):110-6. PubMed ID: 1705176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin-2 on the ex vivo growth of human myeloma cells.
    Peest D; de Vries I; Hölscher R; Leo R; Deicher H
    Cancer Immunol Immunother; 1989; 30(4):227-32. PubMed ID: 2532059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells.
    Stoeck M; Marland-Noske C; Manasterski M; Zawatzky R; Horn S; Möbus V; Schlag P; Schirrmacher V
    Cancer Immunol Immunother; 1993 Sep; 37(4):240-4. PubMed ID: 8348563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.
    Whiteside TL
    Clin Diagn Lab Immunol; 2000 May; 7(3):327-32. PubMed ID: 10799441
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations.
    Kotwal A; Gustafson MP; Bornschlegl S; Kottschade L; Delivanis DA; Dietz AB; Gandhi M; Ryder M
    Thyroid; 2020 Oct; 30(10):1440-1450. PubMed ID: 32323619
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4
    Choi YJ; Park HJ; Park HJ; Jung KC; Lee JI
    J Immunol Res; 2018; 2018():3861079. PubMed ID: 30116750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
    Waschbisch A; Sammet L; Schröder S; Lee DH; Barrantes-Freer A; Stadelmann C; Linker RA
    Clin Exp Immunol; 2014 Aug; 177(2):404-11. PubMed ID: 24730443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro induction of regulatory CD4+CD8α+ T cells by TGF-β, IL-7 and IFN-γ.
    Van Kaer L; Rabacal WA; Scott Algood HM; Parekh VV; Olivares-Villagómez D
    PLoS One; 2013; 8(7):e67821. PubMed ID: 23844100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
    Desfrançois J; Moreau-Aubry A; Vignard V; Godet Y; Khammari A; Dréno B; Jotereau F; Gervois N
    PLoS One; 2010 Jan; 5(1):e8437. PubMed ID: 20052413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease.
    Das G; Augustine MM; Das J; Bottomly K; Ray P; Ray A
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5324-9. PubMed ID: 12695566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat.
    Kenny E; Mason D; Pombo A; Ramírez F
    Immunology; 2000 Oct; 101(2):178-84. PubMed ID: 11012770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.
    Sakkas LI; Platsoucas CD
    Immunol Res; 1995; 14(3):218-36. PubMed ID: 8778211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double-positive T cells.
    Zuckermann FA; Husmann RJ
    Immunology; 1996 Mar; 87(3):500-12. PubMed ID: 8778040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of porcine CD4/CD8 double-positive T lymphocytes in mucosa-associated lymphoid tissues.
    Zuckermann FA; Gaskins HR
    Immunology; 1996 Mar; 87(3):493-9. PubMed ID: 8778039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular heterogeneity of a Graves' thyroid-infiltrating T cell population rich in CD8+ and gamma delta+ T cells.
    Santamaria P; Lewis C; Barbosa JJ
    J Endocrinol Invest; 1993 Dec; 16(11):913-20. PubMed ID: 8144870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor gamma/delta+ lymphocyte subsets during HIV infection.
    Autran B; Triebel F; Katlama C; Rozenbaum W; Hercend T; Debre P
    Clin Exp Immunol; 1989 Feb; 75(2):206-10. PubMed ID: 2522839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.